Che-Chang Chan

504 total citations
15 papers, 404 citations indexed

About

Che-Chang Chan is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, Che-Chang Chan has authored 15 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 11 papers in Epidemiology and 3 papers in Physiology. Recurrent topics in Che-Chang Chan's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (10 papers) and Liver physiology and pathology (3 papers). Che-Chang Chan is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (10 papers) and Liver physiology and pathology (3 papers). Che-Chang Chan collaborates with scholars based in Taiwan and United States. Che-Chang Chan's co-authors include Han‐Chieh Lin, Yi‐Hsiang Huang, Kuei‐Chuan Lee, Yun-Cheng Hsieh, Shou‐Dong Lee, Ying‐Ying Yang, Fa‐Yauh Lee, Hung-Hsu Hung, Ming-Chih Hou and Teh‐Ia Huo and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Che-Chang Chan

15 papers receiving 397 citations

Peers

Che-Chang Chan

HEPAT

EPIDE

SURGE

EDM

Erica Lafoz Spain

Yun-Cheng Hsieh Taiwan

Yun‐Cheng Hsieh Taiwan

R H Lu Taiwan

M. Siciliano Italy

Carmen Zafra Spain

Selim Giray Nak Türkiye

Chung‐Te Hsu Taiwan

Mauricio R. Loureiro‐Silva United States

Erica Lafoz Spain

Che-Chang Chan

398 ×1.5

HEPAT

400 ×1.5

EPIDE

121 ×1.2

SURGE

67 ×1.3

28 ×0.6

EDM

Citations per year, relative to Che-Chang Chan Che-Chang Chan (= 1×) peers Erica Lafoz

Countries citing papers authored by Che-Chang Chan

Since Specialization

Citations

This map shows the geographic impact of Che-Chang Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che-Chang Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che-Chang Chan more than expected).

Fields of papers citing papers by Che-Chang Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Che-Chang Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che-Chang Chan. The network helps show where Che-Chang Chan may publish in the future.

Co-authorship network of co-authors of Che-Chang Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Che-Chang Chan. A scholar is included among the top collaborators of Che-Chang Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Che-Chang Chan. Che-Chang Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hsieh, Yun-Cheng, Hao-Jan Lei, Keng‐Hsin Lan, et al.. (2021). (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway. Cellular and Molecular Gastroenterology and Hepatology. 12(3). 813–838. 18 indexed citations

Lee, Kuei‐Chuan, Yun-Cheng Hsieh, Che-Chang Chan, et al.. (2019). Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease. Laboratory Investigation. 99(8). 1203–1216. 25 indexed citations

Lee, Kuei‐Chuan, Wei‐Fan Hsu, Yun-Cheng Hsieh, et al.. (2018). Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats. Digestive Diseases and Sciences. 64(1). 102–112. 27 indexed citations

Lee, Kuei‐Chuan, Yun-Cheng Hsieh, Ying‐Ying Yang, et al.. (2016). Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice. Scientific Reports. 6(1). 18899–18899. 20 indexed citations

Yang, Ying‐Ying, Shie‐Liang Hsieh, Yi‐Chen Yeh, et al.. (2014). Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites. Journal of Hepatology. 61(5). 1004–1013. 28 indexed citations

Lee, Kuei‐Chuan, Che-Chang Chan, Ying‐Ying Yang, et al.. (2013). Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet. PLoS ONE. 8(10). e77817–e77817. 23 indexed citations

Chan, Che-Chang, Jean Lu, Yi‐Hsiang Huang, et al.. (2012). The Role of Interferon-γ Inducible Protein-10 in a Mouse Model of Acute Liver Injury Post Induced Pluripotent Stem Cells Transplantation. PLoS ONE. 7(12). e50577–e50577. 11 indexed citations

Hung, Hung-Hsu, Ming-Chih Hou, Wei‐Chih Liao, et al.. (2012). Efficacy of non-selective β-blockers as adjunct to endoscopic prophylactic treatment for gastric variceal bleeding: A randomized controlled trial. Journal of Hepatology. 56(5). 1025–1032. 52 indexed citations

Hsieh, Yun-Cheng, Che-Chang Chan, Kuei‐Chuan Lee, et al.. (2012). Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic rats. Journal of the Chinese Medical Association. 75(10). 501–508. 10 indexed citations

10.

Yang, Ying‐Ying, Tung‐Hu Tsai, Tzung-Yan Lee, et al.. (2011). Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats. Hepatology. 55(5). 1540–1550. 37 indexed citations

11.

Hung, Hung-Hsu, Chien‐Wei Su, Chiung‐Ru Lai, et al.. (2010). Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatology International. 4(4). 691–699. 58 indexed citations

12.

Su, Chien‐Wei, Che-Chang Chan, Hung-Hsu Hung, et al.. (2009). Predictive Value of Aspartate Aminotransferase to Alanine Aminotransferase Ratio for Hepatic Fibrosis and Clinical Adverse Outcomes in Patients With Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. 43(9). 876–883. 27 indexed citations

13.

Lin, Han-Chieh, et al.. (1999). Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension. Journal of Hepatology. 30(6). 1105–1111. 9 indexed citations

14.

Chan, Che-Chang, et al.. (1999). Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: Role of nitric oxide and prostaglandin. Hepatology. 30(3). 630–635. 51 indexed citations

15.

Chan, Che-Chang, Fa‐Yauh Lee, Sun-Sang Wang, et al.. (1998). Chronic Administration of Octreotide Ameliorates Portal Hypertension and Portal Hypertensive Gastropathy in Rats with Cirrhosis. Clinical Science. 94(4). 367–371. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact